After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...

Flywheel, the leading medical imaging data management and analysis platform, today announced key milestones achieved in 2025. The company also recently closed on an oversubscribed $25 million ...

The funding will enable further international expansion, as well as development of the company’s Omnichannel partner ...

New York City-based Mount Sinai’s Tisch Cancer Center has launched a new AI platform designed to help more cancer patients across its health system find and enroll in clinical trials. The platform, ...

TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced today the opening of TrialAssure B.V., its new European office located in ...

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has ...

Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

The TIGIT inhibitors market is poised for growth with the anticipated drug approval by 2030, over 40 drugs in clinical trials, and a dynamic landscape involving major pharmaceutical and biotech firms.

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

The Clinical Trials Office at Saint Louis University supports innovative clinical investigative research at the SLU School of Medicine. Our office provides clinical trial management for ...